Drawing for CORESIGHT

USPTO serial 86471313

CORESIGHT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
OLANDRIA, WARREN
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CORESIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Philip A. Jones

PHILIP A. JONES BRINKS GILSON & LIONEP.O. BOX 10395CHICAGO, IL 60610UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, biochemical reagents used for non-medical purposes; Biochemicals, namely, enzymes for scientific and research purposes; Chemical preparations and substances, namely, fluorescent dye for scientific or research use; Surfactant; Dye for staining cells; Dye for staining nucleic acid; Chemical compound for dispersing cells; and Chemical preparations and substances, namely, cleaning solutions used for cytometersACTIVE—
005Medical and pharmaceutical preparations; Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Testing reagents and preparations for medical or veterinary purposes; Pharmaceutical preparations for in vitro diagnosis; Reagents for genetic test for medical or veterinary purposes; Diluents for medical or clinical diagnostic use; Diluents for genetic test for medical or veterinary purposes; Dye solution for medical or clinical diagnostic use; Dye solution for genetic test for medical or veterinary purposes; Nucleic dye for medical or clinical diagnostic use; Nucleic dye for genetic test for medical or veterinary purposes; Enzyme for pretreatment of cells; Reference control materials for medical or veterinary use; Chemical reference materials for medical or veterinary use; Quality control standard solutions and quality control reagents for testing; Calibrating medical apparatus and reagents; and Sanitary preparations for medical purposes all of the foregoing for use with cancer diagnosisACTIVE—
009Testing apparatus and instruments for scientific or laboratory use, namely, flow cytometer; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; Cytometer for scientific or laboratory use; Cell analyzer for scientific or laboratory use; Genetic analyzer for scientific or laboratory use; Computer; Computer software for use in the field of medical, clinical, diagnostic or laboratory analysis; Computer program for use in the field of medical, clinical, diagnostic or laboratory analysis; and Structural parts and fittings for the aforementioned goods all of the foregoing for use with cancer diagnosisACTIVE—
010Apparatus and instruments for medical purposes; Cell analyzer for medical purposes; Flow cytometer for medical purposes; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical diagnostic use; Instrument and apparatus systems for medical diagnostic use employing flow cytometer, sample preparation device, and related data management software sold as a unit; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Diagnostic apparatus for the detection of cancer; Medical apparatus for detecting cancer; Filters for medical purposes, namely, filters for capturing cells; Containers for samples for in vitro diagnosis; Sampling bottles and disposable beakers; and Structural parts and fittings for all the aforementioned goods all of the foregoing for use with cancer diagnosisACTIVE—
042Medical and scientific research in the field of cancer diagnosis; Providing information about medical research in the field of cancer diagnosis; Testing, examination or research of pharmaceutical preparations and diagnostic reagents; Testing, examination or research of medical, laboratory, measuring or testing apparatus and instruments; Technical advice relating to performance and operation of medical, laboratory, measuring or testing apparatus and instruments and computers that require high levels of personal knowledge, skill or experience of the operators to meet the required accuracy in operating them; Rental of testing apparatus and instruments for scientific or laboratory use; Rental of laboratory apparatus and instruments; and Rental of testing apparatus and instruments all of the foregoing for use with cancer diagnosisACTIVE—
044Clinical laboratory testing; Providing information about clinical laboratory tests; Analysis and evaluation of results of clinical laboratory tests; Providing medical information; and Rental of medical apparatus and instruments all of the foregoing for use with cancer diagnosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 15, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 15, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 4, 2015LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Apr 27, 2015LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Mar 19, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2015DOCKASSIGNED TO EXAMINER—
Dec 10, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance